The impact of generic goods in the pharmaceutical industry

Health Economics

Volumn 8, Issue 7, 1999, Pages 599-612

  Ferrándiz, Jorge Mestre ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Generic goods; Market segmentation; Pharmaceutical industry

Indexed keywords

GENERIC DRUG;

ARTICLE; DRUG INDUSTRY; MARKET; PATENT; PRIORITY JOURNAL;

DRUG INDUSTRY; DRUGS, GENERIC; ECONOMIC COMPETITION; ECONOMICS, PHARMACEUTICAL; EUROPE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MODELS, ECONOMETRIC; UNITED STATES;

EID: 17744403232     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199911)8:7<599::AID-HEC479>3.0.CO;2-K     Document Type: Article

References (12)

1. National Economic Research Associates. El Sistema Sanitario Español: Alternativas pare su Reforma, Madrid, 1997.
2. de Wolf, P. The pharmaceutical industry: structure, intervention and competitive strength. In: de Jong, H.W. (ed.), The structure of European industry, Dordrecht: Kluwer Academic Publishers, 1988.
3. El Pais, Thursday, 19 February 1998, p. 25.
4. Caves, R., Whinston, M. and Hurwitz, M. Patent expiration, entry, and competition in the US pharmaceutical industry. Brookings Papers on Economic Activity: Microeconomics 1991; 1-48.
5. Frank, A. and Salkever, D. Generic entry and the pricing of pharmaceuticals. Journal of Economics and Management Strategy 1997; 6: 75-90.
6. Frank, A. and Salkever, D. Pricing, patent loss and the market for pharmaceuticals. Southern Economic Journal 1992; 59: 165-179.
7. Grabowski, H. and Vernon, J. Brand loyalty, entry and price competition in pharmaceuticals after the 1984 Drug Act. Journal of Law and Economics 1992; XXXV: 331-350.
8. Scherer, F. Pricing, profits, and technological progress in the pharmaceutical industry. Journal of Economic Perspectives 1993; 7: 97-115.
9. Masson, A. and Steiner, R. Generic substitution and prescription drug prices: economic effects of state drug product selection laws. Washington: Federal Trade Commission, 1985.
10. Lobo, F. La Creación de un mercado de medicamentos genericos en España. FEDEA 1996; 1-62. In: Lopez-Casasnovas, G. and Rodriguez, D. (eds.), La Regulación de los servicios sanitarios en España, Biblioteca Civitas Economia y Empresa, Editorial Civitas, Madrid, 1997.
11. Lobo, F. La Creación de un mercado de medicamentos genericos en España. FEDEA 1996; 1-62. In: Lopez-Casasnovas, G. and Rodriguez, D. (eds.), La Regulación de los servicios sanitarios en España, Biblioteca Civitas Economia y Empresa, Editorial Civitas, Madrid, 1997.
12. Liang, B. The anticompetitive nature of brand-name firm introduction of generics before patent expiration. The Antitrust Bulletin 1996; XLI: 599-635.